In a preview of the session "Emerging Directions in Diabetic Neuropathy" at the American Diabetes Association 82nd Scientific Sessions, the ADA interviewed Dr. Eid about her upcoming talk, "Mitochondria as New Therapeutic Targets in Diabetic Neuropathy."
When two separate ALS diagnoses touched the lives of Bob & Joan Epstein, they sprang to action and funded the Robert A. Epstein and Joan M. Chernoff-Epstein Fund for Innovative Therapies and the Robert A. Epstein and Joan M. Chernoff-Epstein Emerging Scholar.
After a two-year hiatus, the Michigan Baseball ALS Awareness game returns on May 17 at 6 PM against the Michigan State Spartans.
Dr. Murdock Talks About His Research and Thanks Bob and Joan Epstein.
The article features Dr. Eva Feldman's Frontiers of Neuroscience Plenary Session at the American Academy of Neurology's Annual Meeting in Seattle.
Dr. Elafros was interviewed about her recent viewpoint in JAMA Neurology: "
The Global Burden of Polyneuropathy—In Need of an Accurate Assessment"
Charlene Handleman's generous support will allow Dr. Chen to advance his groundbreaking work utilizing the unique properties of stem cells to understand what causes neurodegenerative diseases, like ALS and Alzheimer’s disease, and advancing the use of the stem cells themselves as a potential treatment agent for such devastating diseases.
Celebrating it's 20th Anniversary Issue and ALS Awareness Month in May, The Lancet Neurology published two articles by our researchers.
Staff from the Pranger ALS Clinic at Michigan Medicine teamed up to join Active Against ALS for their Annual Box Car Derby.
In honor of Women's History Month, we put together a timeline of women who shaped neuroscience as we know it today.
A lot is known about the micro and macrovascular complications of diabetes, but not much research has been done to understand if it also causes neuropsychological conditions—mental health disorders, cognitive disorders, chronic pain, addiction, and sleep disorders. New research by Reynolds et al, published in Frontiers in Endocrinology, does
In 10 Questions with Phillipe O'Brien, we catch up with the former postdoctoral fellow who has gone back to his Irish roots.
In 10 Questions Lisa McGinley, we catch up with the former Handleman Emerging Scholar, whose journey from Ireland continues as she moves further west to the Golden State.
U-M's Office of Campus Sustainability raised the NeuroNetwork for Emerging Therapies lab's rating from gold to platinum level (the highest possible), as part of the Planet Blue Campus—commitment to sustainability—initiative.
The theme for this year is "Everyone Needs to Act." We did just that and created an infographic chalked full of reasons why obesity is something we cannot ignore.
She explains the heightened risk of ALS for military veterans in a story of a 41-year-old woman diagnosed with the deadly disease who is raising funds to advance research.
Dr. Rodica Pop-Busui edited the 2022 edition of the American Diabetes Association's (ADA) Clinical Compendium on "Diagnosis and Treatement of Painful Diabetic Peripheral Neuropathy," which featured a section on "Pathophysiology of Diabetic Peripheral Neuropathy" written by Dr. Eva Feldman.
NeuroNetwork team member offers the first article for the international group of promising young scientists that publishes the latest news and research for the diabetic neuropathy community.
Watch the Chair of Restorative Neuroscience at Imperial College London give a snapshot of the presentation he recently gave during a NeuroNetwork for Emerging Therapies lab session.
We wore red today to support the incredible lifesaving work by our friends and colleagues at the Frankel Cardiovascular Center and their efforts to combat heart disease and stroke.
